Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kytta-Balsam f versus methyl nicotinate alone or placebo for acute back pain
2008-008721-29Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Kytta-Balsam f, methylnicotinate and comfrey root extract in acute lumbago (3 arms), sponsored by Merck & Co. Primary endpoint: Primary efficacy endpoint. Started May 2009; status: completed.
02
Drugs
Kytta-Balsam fmethylnicotinatecomfrey root extract
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2008-008721-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008721-29.